Regeneron
Medicine, science, health, global
- B2B
- Has physical offices
- Publicly traded
- Manufacturing
- Sales-led purchase
About Regeneron
Develops and commercializes life-transforming medicines for serious diseases, establishing new approaches in science, manufacturing, and health. Building a future in biopharmaceuticals.
Key facts
- Industry
- Biotechnology
- Company size
- 10,000+ employees
- Headquarters
- Tarrytown, New York, United States
- Revenue
- $14.3BFY2025, publicly reported
- Website
- regeneron.com
Jobs at Regeneron
- Senior Product Manager, Predictive Analytics
- Executive Director: Data Management, Analytics, AI & Architecture
- Director Integrated Data Quality
- Director, Data Management Process, Quality & Inspection Readiness
- VP Enterprise Data & Information Management
- Director, Data Governance and Contract Compliance, Regeneron Genetics Center (RGC)
- Director Quality Assurance, Drug Substance Manufacturing
- Executive Director - Data Management, Analytics, AI & Architecture
Regeneron in the news
- Regeneron Pharmaceuticals, Inc. (REGN) Discusses Expanded Collaboration on Next-Generation Long-Acting Immunology Antibodies - Slideshow (NASDAQ:REGN) 2026-10-01
Regeneron Pharmaceuticals published a slide deck about an expanded collaboration on next-generation long-acting immunology antibodies.
- #EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy
Regeneron's investigational antibody helps obesity patients recover muscle mass lost after stopping GLP-1 therapy like Novo's Wegovy.
- Sanofi and Regeneron expand global alliance
Sanofi and Regeneron expanded their global antibody collaboration, adding next-generation antibodies and building on the success of Dupixent.
- Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor
Sanofi paid Regeneron $1 billion upfront to renew their partnership, developing four next-generation antibodies for immune-mediated conditions as potential successors to Dupixent.
- Sanofi forges new $8bn pact with Regeneron
Sanofi and Regeneron expanded their R&D alliance with an $8 billion pact for four new medicines, building on their successful collaboration history.
Regeneron at a glance
Regeneron is a B2B company in the Biotechnology industry, headquartered in Tarrytown, New York, United States.
Regeneron has 10,000+ employees.
Regeneron's revenue is $14.3B (FY2025, publicly reported).
Regeneron is hiring: 8 recent open roles, including Senior Product Manager, Predictive Analytics, Executive Director: Data Management, Analytics, AI & Architecture, Director Integrated Data Quality.
Selling to companies like Regeneron?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies